Fuisz Pharma LLC v. Theranos Inc.
5:12-cv-03323
Overview
Parties
Defendant
Theranos Inc. Operating Company
Represented By
8 Attorneys ListedBoies Schiller and Flexner LLP
333 Main Street, Armonk, NY 10504
Boies Schiller and Flexner LLP
575 Lexington Avenue, 7th Floor, New York, NY 10022
DLA Piper LLP (US)
2000 Avenue of the Stars, Suite 400, North Tower
Boies Schiller & Flexner LLP
333 Main St, Armonk, NY 10504
Boies Schiller & Flexner LLP
333 Main Street, Armonk, NY 10504
The Norton Law Firm
299 Third Street, Suite 200, Oakland, CA 94607
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
Hercules Plaza, P.O. Box 951
Plaintiff
Fuisz Pharma LLC Operating Company
Represented By
4 Attorneys ListedMorris Nichols Arsht and Tunnell
Morris Nichols Arsht and Tunnell, 1201 N. Market Street
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Law Office of Katherine R Moore
600 Allerton Street, Suite 202, Redwood City, CA 94063
Court & Judges
Court
District Court, N.D. California (cand)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7824612
Bodily fluid analyzer, and system including same and method for programming same
|
Filed: 2007-04-24
Issued: 2010-11-02
|
Expiring Soon (155 days)
Expires: 2027-04-24
|
Patent Enforceability & Injunction Risk Assessment
Narrowing Window β Imminent expiration makes injunctive relief unlikely to be granted.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.
Procedural Motions & Interlocutory Orders
Total Motions
19
Dispositive
12
Granted
0
Denied
0
Pending / Review
10
Motions by Category
Key Dispositive Motions & Rulings